Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

End in sight for US ban on unapproved devices literature

This article was originally published in Clinica

Executive Summary

The US FDA has indicated it may lift its prohibition on manufacturers' dissemination of textbooks and peer-reviewed articles that describe unapproved uses of medical devices. The agency last week announced that it "has determined that distribution [to healthcare professionals] of textbooks that do not highlight unapproved uses should be permitted. Similarly ... the FDA has determined that certain peer-reviewed journal reports upon which FDA relied for approval of a product may be distributed even if they contain information (eg reference to unapproved uses) that is inconsistent with the FDA-approved labelling for the product."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT094263

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel